Vaccines & Therapeutic Options

Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Pfizer/BioNTech Vaccine Judged Safe for use in UK From Next Week
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study COVID-19 Vaccine Candidate; Filing Today with FDA for EUA
3rd Major COVID-19 Vaccine Shown to be Effective and Cheaper
FDA OKs Monoclonal Antibody Cocktail for Less Severe COVID-19
FDA OKs JAK Inhibitor and Remdesivir Combo for Severe COVID-19

Pfizer, BioNTech To Seek Emergency COVID-19 Vaccine Nod …
Pfizer and Biontech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
Moderna’s Vaccine Candidate Meets its Primary Efficacy Endpoint …

Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures

Pfizer and Biontech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis From Phase 3 Study
Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate

Updated: FAQs about COVID-19 Vaccination
FDA: COVID-19 Vaccines
HHS: Trump Administration Partners with CVS & Walgreens to Provide COVID-19 Vaccine to Protect Vulnerable Americans in Long-Term Care Facilities Nationwide
HHS: Trump Administration Takes Action to Further Expand Access to Vaccines, COVID-19 Tests
NIH: Clinical Trials Site

Covid-19 Vaccine Trial Participant Had Serious Neurological Symptoms, But . . . , AstraZeneca CEO Says
Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
Moderna Publishes in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
COVID-19 Antibody Trials Have Begun
Monoclonal Antibodies for Prevention and Treatment of COVID-19

NIH Clinical Trials: Safety/Immunogenicity Study of COVID-19 Vaccine for Prophylaxis of COVID-19 Infection
Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
Moderna Publishes in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
COVID-19 Antibody Trials Have Begun
Monoclonal Antibodies for Prevention and Treatment of COVID-19